Parkinson’s disease is commonly treated with dopamine precursors (levodopa/carbidopa) and dopamine agonists (pramipexole and ropinirole).

Authors

• Person: Colten HR, Altevogt BM Organization: National Academies Press
  Extent and Health Consequences of Chronic Sleep Loss and ... - NCBI

Sources

• Extent and Health Consequences of Chronic Sleep Loss and ... - NCBI www.ncbi.nlm.nih.gov Colten HR, Altevogt BM · National Academies Press via serper

Referenced by nodes (2)

• Parkinson's disease concept
• dopamine agonists concept